Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.

about

Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients.

P2860

Q36602293-96368F9A-DEA9-43AC-863B-2EE576DC9483

P2860

Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.

Item

http://www.wikidata.org/entity/Q38995225

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Polymorphisms at IL28B gene as ...... Egyptian hepatitis C patients.

@en

type

Item

label

Polymorphisms at IL28B gene as ...... Egyptian hepatitis C patients.

@en

prefLabel

Polymorphisms at IL28B gene as ...... Egyptian hepatitis C patients.

@en

P1476

Polymorphisms at IL28B gene as ...... Egyptian hepatitis C patients

@en

P2093

Eman Ramadan Ghazawy

http://www.w3.org/2001/XMLSchema#string

Mohamed Abdel-Hamid

http://www.w3.org/2001/XMLSchema#string

Mona Abdelmonem Esmail

http://www.w3.org/2001/XMLSchema#string

Noha A Hassuna

http://www.w3.org/2001/XMLSchema#string

P2860

Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance

Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy

Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C

Telaprevir for previously untreated chronic hepatitis C virus infection

P304

481-486

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JMV.24354

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Khalda S. Amr

P577

2015-08-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281081682

http://www.w3.org/2001/XMLSchema#string

P698

26280154

http://www.w3.org/2001/XMLSchema#string

Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.

about

P2860

P2860

Polymorphisms at IL28B gene as predictors of viral relapse in genotype 4 Egyptian hepatitis C patients.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698